Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

OPENLANE Q3 2026: GMV Hits $10 Billion, 38% Growth

OPENLANE, Inc. (NYSE:OPLN) reported its third quarter 2026 financial results on November 4, 2026, for the period ended September 30, 2026, disclosing revenue of $561 million, net income of $44.7 million, and Gross Merchandise Value of approximately $10.0 billion.

Shwetambri Chauhan | 04 November 2026

Criteo Q3 2026: Revenue Falls 11%, Media Spend Rises 9%

Criteo S.A. (NASDAQ:CRTO) reported its third-quarter financial results for the period ended September 30, 2026, disclosing an 11% year-over-year decline in GAAP revenue alongside a 9% constant-currency increase in media spend, in a filing released November 4, 2026.

Aakashdeep | 04 November 2026

Criteo Expands Performance CTV Beyond U.S. to 10+ Markets

Criteo (NASDAQ:CRTO) issued a press release on November 4, 2026, announcing the global expansion of its Performance Connected TV capabilities to Brazil, Mexico, and additional markets beginning by the end of 2026 and continuing through 2027.

Shwetambri Chauhan | 04 November 2026

UCB Selects Veeva Vault CRM for Commercial Operations

Veeva Systems filed an 8-K press release on November 4, 2026, announcing that UCB has selected Veeva Vault CRM as its agent-based customer engagement platform for life sciences commercial operations.

Anjali Anand | 04 November 2026

Advantage Solutions Reports Q3 2026 Earnings Results

Advantage Solutions Inc. filed a Current Report on Form 8-K on November 4, 2026, disclosing the release of its financial results for the third quarter ended September 30, 2026, along with an accompanying earnings presentation.

Nitish Kishor | 04 November 2026

Genprex TROP2 Biomarker Data for Reqorsa Set for EORTC 2026

Genprex, Inc. filed a Form 8-K on November 4, 2026, announcing that new research identifying TROP2 expression as a potential predictive biomarker of response to its lead drug candidate, Reqorsa (quaratusugene ozeplasmid), will be presented at the 2026 EORTC-NCI-AACR Symposium in Barcelona, Spain.

Nitish Kishor | 04 November 2026

CPI Card Group Files Q3 2026 Earnings 8-K

CPI Card Group Inc. filed a Form 8-K on November 4, 2026, announcing the availability of its financial results for the fiscal quarter ended September 30, 2026, along with a related investor presentation.

Vinay Lochav | 04 November 2026

Insulet Adds $1 Billion Buyback, Plans $400M in Q4 2026

Insulet Corporation filed a Form 8-K on November 4, 2026, disclosing a new $1 billion stock repurchase program authorized by its Board of Directors on October 30, 2026, alongside an announcement of third-quarter 2026 financial results.

Nitish Kishor | 04 November 2026

D-Wave Enhances Stride Solver, Launches Quantum Learning Path

D-Wave Quantum Inc. filed a Form 8-K with the SEC on November 4, 2026, disclosing performance enhancements to its Stride hybrid solver and the launch of a new three-course Applied Quantum Optimization learning path.

Aditi Sarkar | 04 November 2026

Camtek Q3 2026 Revenue Hits $161.3M, Eyes $180M in Q4

Camtek Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on November 4, 2026, reporting financial results for the third quarter ended September 30, 2026, including record quarterly revenues and updated forward-looking expectations for the remainder of 2026 and full-year 2027.

Anjali Anand | 04 November 2026
Support

Hi! How can we help you today?

Loading…